Compounded semaglutide and tirzepatide often cost about $200 to $600 per month, which can mean savings of 60% to 85% compared with brand-name versions
To address this problem, we generated a new database of compounds, AqSolDB, by merging a total of nine different aqueous solubility datasets, curating the merged data, standardizing and validating the compound representation formats, marking with reliability labels, and providing 2D descriptors of compounds as a Supplementary Resource
First, the effect is real, dose-dependent, and reproducible this is not speculative pharmacology
Polynucleotides and PRP may also be effective
Fetal anomalies targeted with prenatal pharmacotherapy are a heterogeneous group of structural, endocrine, and metabolic conditions, including brain and spine anomaly, hyaline membrane disease prevention, congenital cystic adenomatoid malformation (CCAM), congenital adrenal hyperplasia, congenital heart block, fetal tachyar- rhythmia, inborn errors of metabolism, fetal thyroid disorders, and polyhydramnios